Also listed on Clarus Therapeutics, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Apr 12, 2030 · High confidence
20-year base term ends Apr 12, 2030
Held by Tolmar, Inc.
Filed Dec 16, 2016 as application 15/381,430 · Granted Apr 14, 2020
Base term, 20 years from filing
Today
2010
2030
Clock starts
Apr 12, 2010
Apr 12, 2010
Term ends
Apr 12, 2030
Apr 12, 2030
Granted
Apr 14, 2020
Apr 14, 2020
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,543,219, US 8,492,369, US 8,778,916, to Apr 12, 2030. The term already ends on or before that date, so the cap shortened nothing.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
34
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 2 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 12, 2010, when application 12/758,770, the earliest non-provisional in its chain, was filed (this one was filed Dec 16, 2016) | Apr 12, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,543,219, US 8,492,369, US 8,778,916) | resolves to Apr 12, 2030, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 12, 2030 | High confidence |
This family
| Application 60/671,454 | Pending not computed | not computed |
| US 8,492,369 | In force Dec 2030 | Dec 2030 |
| US 8,778,916 | In force Apr 2030 | Apr 2030 |
| Application 61/830,531 | Pending not computed | not computed |
| Application 61/920,982 | Pending not computed | not computed |
| Application 14/216,240 | Abandoned not computed | not computed |
| Application 14/290,540 | Abandoned not computed | not computed |
| Application 62/073,701 | Provisional application no patent term | no patent term |
8 of 34 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 12, 2017 Reel 40958, frame 709 | Dudley, Robert E; Constantinides, Panayiotis P | Clarus Therapeutics, Inc. | Assignment of Assignor's Interest |
| Mar 12, 2020 Reel 52099, frame 349 | Clarus Therapeutics, Inc. | U.S. Bank National Association | Security Interest |
| Nov 15, 2022 Reel 61774, frame 516 | Clarus Therapeutics, Inc. | Tolmar, Inc. | Assignment of Assignor's Interest |
| Dec 6, 2022 Reel 62000, frame 52 | U.S. Bank Trust Company, National Association, as Successor to U.S. Bank National Association | Clarus Therapeutics, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Apr 2030
Term ends Apr 12, 2030. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 10,543,219, US 8,492,369, US 8,778,916, ends no earlier than this term, so it caps nothing.
Citations
13
later US patents cite this one
That is top 25% of utility patents granted in 2020 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.